ACIâ„¢-Georgia Program Schedule and Faculty

Friday, September 18, 2015 • 8 a.m. – 4 p.m. • Georgia Regents University

Presentations include allotted time for Audience Response System (ARS) assisted audience
interaction as well as general question and answer time.

As of 7/24/15

7:00 a.m. – 8:00 a.m.	Registration and Networking Breakfast
8:00 a.m. – 8:10 a.m.	Welcome and Introductions
Session I: Principles of Tumor Immunology 1.25 AMA PRA Category 1 Credits™
8:10 a.m. – 8:35 a.m.	Immunology 101 for the Non-Immunologist   Esteban Celis, MD, PhD – Georgia Regents University Center
8:35 a.m. – 9:00 a.m.	Basic Principles of Tumor Immunotherapy   Samir N. Khleif, MD – Georgia Regents University Cancer Center
9:00 a.m. – 9:25 a.m.	Basic Mechanisms of Tumor Immune Suppression   Zihai Li, MD, PhD – Medical University of South Carolina
9:25 a.m. – 9:40 a.m.	Break
Session II: Major Approaches to Tumor Immunotherapy – What the Clinician Needs to Know 2.5 AMA PRA Category 1 Credits™
9:40 a.m. – 10:05 a.m.	Cytokines: Interferons, Interleukins and Beyond Mark Rubinstein, PhD - Medical University of South Carolina
10:05 a.m. – 10:30 a.m.	Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies John E. Janik, MD – Georgia Regents University Center
10:30 a.m. – 10:55 a.m.	Active Immunization Approaches   Yukai He, PhD – Georgia Regents University
10:55 a.m. – 11:20 a.m.	Current Status of Chimeric and Adoptive T Cell Therapy   Chrystal Paulos, PhD - Medical University of South Carolina
11:20 a.m. – 11:45 a.m.	Is There a Role for Radiation Therapy and Immunotherapy?   Lewis Cooper, MD -  Medical University of South Carolina
11:45 a.m. – 12:15 p.m.	Panel Discussion
12:15 p.m. – 1:00 p.m.	Lunch
Session III: The Role of Tumor Immunotherapy for Cancer – Clinical Indications and Patient Management 2.75 AMA PRA Category 1 Credits™
1:00 p.m. – 1:20 p.m.	Immune-Related Adverse Events   Asha Nayak-Kapoor, MD – Georgia Regents University
1:20 p.m. – 1:40 p.m.	Immunotherapy for the Treatment of Melanoma John Wrangle, MD - Medical University of South Carolina
1:40 p.m. – 2:00 p.m.	Immunotherapy for the Treatment of Hematologic Malignancies   Xue-Zhong Yu, MD – Medical University of South Carolina
2:00 p.m. – 2:20 p.m.	Immunotherapy for the Treatment of Non-Small Cell Lung Carcinoma   Zhonglin Hao, MD, PhD - Georgia Regents University
2:20 p.m. – 2:35 p.m.	Break
2:35 p.m. – 2:55 p.m.	Immunotherapy for the Treatment of GU Malignancies   Jennifer Wu, PhD – Medical University of South Carolina
2:55 p.m. – 3:15 p.m.	Immunotherapy for the Treatment of Brain Malignancies   Theodore Johnson, MD, PhD – Georgia Regents University
3:15 p.m. – 3:45 p.m.	Panel Discussion
3:45 p.m. – 4:00 p.m.	Closing Remarks

Back to Advances in Cancer Immunotherapy^TM-Georgia General Information